Drug eruptions and the vulva.
Journal
Clinical and experimental dermatology
ISSN: 1365-2230
Titre abrégé: Clin Exp Dermatol
Pays: England
ID NLM: 7606847
Informations de publication
Date de publication:
31 Oct 2023
31 Oct 2023
Historique:
received:
04
06
2023
revised:
27
09
2023
accepted:
28
10
2023
medline:
3
11
2023
pubmed:
3
11
2023
entrez:
3
11
2023
Statut:
aheadofprint
Résumé
Drug reactions affecting the vulva are understudied and underreported, with some having the potential to cause serious morbidity through long term sequelae. We conducted a literature review to investigate the current evidence about vulval drug eruptions. We aimed to establish the extent of drug reactions affecting the vulva, identify the common culprit drugs and review current evidence and guidelines regarding their management. The vulval involvement seen in Steven-Johnson Syndrome, Toxic Epidermal Necrolysis (SJS/TEN) and Fixed Drug Eruption (FDE) forms the focus of this review, but we also summarise the current evidence regarding less common reactions.
Identifiants
pubmed: 37921355
pii: 7334280
doi: 10.1093/ced/llad369
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of British Association of Dermatologists. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.